Europe — EMA
Octaplex
GNH USA supplies Octaplex (Human Prothrombin Complex Concentrate), a prothrombin complex concentrate for warfarin reversal bleeding control. Request a quote.
Request sourcing
What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?
Human Prothrombin Complex Concentrate, the active ingredient in Octaplex, is a prothrombin complex concentrate presented as an injectable solution for intravenous use. It provides vitamin K‑dependent clotting factors II, VII, IX, X together with proteins C and S to rapidly reverse warfarin anticoagulation, treat bleeding episodes, and replace deficient proteins in acquired or congenital deficiencies.
GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for this injectable product.
What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?
Octaplex, a prothrombin complex concentrate, acts on the vitamin K‑dependent coagulation pathway to restore clotting ability.
- Urgent reversal of warfarin anticoagulation: rapidly restores clotting factors to counteract vitamin K antagonist effect. - Bleeding episodes in factor deficiencies: supplies missing factors II, VII, IX, and X to achieve hemostasis. - Protein C or protein S deficiency management: replaces deficient proteins to normalize anticoagulant balance.
What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?
Octaplex may be associated with infusion‑related reactions and rare serious events.
Common Side Effects: - Injection site erythema or pain - Fever or chills - Headache - Nausea or vomiting - Mild hypotension
Serious or Rare Side Effects: - Thromboembolic events (deep vein thrombosis, pulmonary embolism) - Disseminated intravascular coagulation - Severe allergic reactions or anaphylaxis - Hemolysis - Transmission of infectious agents (theoretical risk)
What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?
Before administering Octaplex, clinicians should observe the following precautions.
- Indication verification: confirm the patient requires rapid reversal of vitamin K antagonist or factor replacement. - Allergy assessment: check for known hypersensitivity to plasma‑derived products. - Thrombotic risk monitoring: observe for signs of thrombosis during and after infusion. - Dose adjustment: base dosing on coagulation test results and clinical response. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?
Octaplex can interact with other agents that affect coagulation.
Major Interactions (Avoid): - Concurrent anticoagulant therapy (e.g., heparin, direct oral anticoagulants): may diminish reversal efficacy. - Use of additional procoagulant agents (e.g., recombinant factor VIIa): increases risk of thrombosis.
Moderate Interactions (Monitor Closely): - Vitamin K supplementation: may alter the required dose of Octaplex. - Antiplatelet drugs (e.g., aspirin, clopidogrel): monitor bleeding status. - High‑dose steroids: may affect plasma protein levels and infusion tolerance.